Webinar series reaches new highs – or today male yeast infection

The recent OR today webinar sponsored by medline set new male yeast infection records with the most registrations and attendees since the series male yeast infection began in 2014! The august 15 webinar “ preventing surgical site infections through a decolonization bundle” was presented by rosie D. Lyles, MD, MHA, msc.

Lyles is the director of clinical affairs at medline industries. She serves as the medical/clinical expert and primary medical science liaison for numerous health male yeast infection care businesses; supporting all scientific research as well as clinical and product male yeast infection intervention design and development. With over a decade of experience investigating hospital associated infections male yeast infection (hais) with a particular focus on the epidemiology and prevention of male yeast infection multidrug-resistant organisms (mdros) such as C. Difficile, MRSA and CRE infections in acute care hospitals and long-term acute care hospitals as a physician and clinical researcher male yeast infection at cook county health and hospitals system. Lyles has directed numerous clinical studies and infection control bundled male yeast infection interventions for the centers for disease control and prevention and male yeast infection the chicago antimicrobial resistance and infection prevention epicenter with numerous male yeast infection authored peer-reviewed journal articles related to infectious disease epidemiology.

During her OR today webinar presentation, lyles discussed the continuous battle of emerging pathogens. She addressed how to prevent the spread of staphylococcus aureus male yeast infection (staph), the leading pathogen that causes healthcare-associated infections (hais) in U.S. Health care facilities? Staph is a common bacteria that can cause serious and male yeast infection costly infections, like surgical site infections, and patients are at higher risk for a staph infection male yeast infection when they have surgery. Current recommendations by health care organizations have led to a male yeast infection reduction in methicillin-resistant staphylococcus aureus (MRSA) in health care, but progress has slowed. In the webinar, lyles explored the benefits of evidence-based decolonization bundles and their critical role in preventing staph male yeast infection infections for patients having surgery.

“this was an excellent overview of literature to support our male yeast infection practice to reduce ssis in our surgical patients. There were two elements of practice that we do not male yeast infection have in our SSI bundle that I will be sharing male yeast infection with our teams. One of the studies discussed the patient risk factors of male yeast infection being either a diabetic, smoker, obese, uses ETOH along with cases that are 140min in length male yeast infection or longer have an increased risk of infection if they male yeast infection possess three or more of these risk factors. The second strategy we need to implement is the CHG male yeast infection bath 2-5 days before surgery,” said S. Bressoud, RN.

“truly enjoyed the webinar – evidence supporting the importance of skin cleansing and proactive measures male yeast infection to decrease ssis was highly evidence-based from peer-reviewed studies. Speaker was knowledgeable and easy to understand. Always look forward to OR today webinars,” clinical educator R. Scott said.

“this was an excellent presentation. Our facility is currently working on an orthopedic and colon male yeast infection surgical site prevention bundle and as an ICP this will male yeast infection assist me in making recommendations for decolonization. Thank you,” said S. LaPisto, RN ICP.

“the webinar offered by OR today was seamless and user-friendly, from the registration, to the calendar appointment, to the log-on and viewing and audio quality of the presentation. The clinical update was helpful, and the offer of contact hours was definitely a plus. I hope to attend more webinars provided by OR today male yeast infection in the near future,” said regional clinical education manager C. Dyer.

“this was a very timely and detailed presentation regarding ssis male yeast infection and prevention strategies. It was an exceptional overview and offered the audience a male yeast infection great deal of evidence-based clinical information to assist with SSI prevention protocols and male yeast infection best practices. Thoroughly enjoyed the speaker, dr. Rosie lyles, and her knowledge of such a critical health care arena,” said N. Cracknell, medical science liaison.

“today’s webinar was extremely informative. This webinar was very much relevant to infection prevention in male yeast infection cardiac patients (and, of course, others). It further cemented the rationales that keep my practice running male yeast infection in an effective manner and ensure that I can speak male yeast infection to patients on the reasons why we do some of male yeast infection the things we do. Thank you and I look forward to upcoming webinars,” said N. Kalleberg, nurse manager, cardiac OR.

“this was my first time attending an OR today webinar male yeast infection and I found the information not only relevant, but critical in the prevention of ssis. I am a nurse by training. I also currently practice as a pre-surgical nurse on a PRN basis in addition to my male yeast infection IP job. It will enhance my knowledge to educate my patients about male yeast infection the risks of SSI and what can be done to male yeast infection prevent it. I will be sure to refer to the evidence presented male yeast infection during the webinar when I am providing education to my male yeast infection patients to ensure their compliance is key in attaining a male yeast infection good surgical outcome,” infection preventionist D. Gelaw said.

“awesome webinar! I loved the research study data showing efficacy, as well as framing past decolonization techniques with new current male yeast infection methods. Really great presenter, easy to understand, hear, perfect delivery pace,” clinical director infection control C. Anderegg said.